Primary sclerosing cholangitis: Outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis

International Journal of Colorectal Disease

Volumn 24, Issue 10, 2009, Pages 1169-1174

  Lepistö, Anna ^a   Kivistö, Sari ^a   Kivisaari, Leena ^a   Arola, Johanna ^b   Järvinen, Heikki J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cholangiocarcinoma; Primary sclerosing cholangitis; Restorative proctocolectomy; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; URSODEOXYCHOLIC ACID;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; CHOLESTASIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; SURGICAL RISK; TREATMENT INDICATION; ULCERATIVE COLITIS;

ANASTOMOSIS, SURGICAL; BIOPSY; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; PROCTOCOLECTOMY, RESTORATIVE; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 69849115706     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0773-4     Document Type: Article

References (22)

1. Fausa O, Schrumf E, Elgjo K (1991) Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liv Dis 11:31-9
2. Aadland E, Schrumf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987) Primary sclerosing cholangitis: Long-term follow-up. Scand J Gastroenterol 22:655-64
3. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Scherlock S (1980) Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology. Gut 21:870-7
4. Helzberg JH, Petersen JM, Boyer JL (1987) Improved survival with primary sclerosing cholangitis. A review of clinicopathological features and comparison of symptomatic and asymptomatic patients. Gastroenterology 92:1869-75
5. Lepistö A, Kärkkäinen P, Järvinen HJ (2008) Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 14:775-9
6. van Leeuwen DJ, Reeders JW (1999) Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol 10(Suppl 4):89-93
7. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM et al (1992) Primary sclerosing cholangitis: Refinement and validation of survival models. Gastroenterology 103:1893-901
8. Lempinen M, Isoniemi H, Mäkisalo H, Nordin A, Halme L, Arola J, Höckerstedt K, Stenman UH (2007) Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures. J Hepatol 47:677-8
9. Hedström J, Haglund C, Haapiainen R, Stenman UH (1996) Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int J Cancer 66:326-31
10. Olsson R, Boberg KM, de Muckadell OS, Lindgren S, Hultcrantz R, Folvik G, Bell H, Gangsoy-Kristiansen M, Matre J, Rydning A, Wikman O, Danielsson A, Sandberg-Gertzen H, Ung KA, Eriksson A, Loof L, Prytz H, Marschall HU, Broome U (2005) High-dose ursodeoxycholic acid in primary sclerosing cholangitis: A 5-year multicenter, randomized, controlled study. Gastroenterology 129:1464-72
11. Mikkola K, Kiviluoto T, Riihelä M, Taavitsainen M, Järvinen HJ (1995) Liver involvement and its course in patients operated on for ulcerative colitis. Hepatogastroenterology 42:68-72
12. Ludwig J, Barham SS, laRusso NF, Elveback LR, Wiesner RH, McCall JT (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1:632
13. Ernst LM, Spinner NB, Piccoli DA, Mauger J, Russo P (2007) Interlobular bile duct loss in pediatric cholestatic disease is associated with aberrant cytokeratin 7 expression by hepatocytes. Pediatr Dev Pathol 10:383-90
14. Yabushita K, Yamamoto K, Ibuki N, Okano N, Matsumura S, Okamoto R, Shimada N, Tsuji T (2001) Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis. Liver 21:50-5
15. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36:321-7
16. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99:523-6
17. Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Friman S, Bjoro K (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40:815-22
18. Mathis KL, Dozois EJ, Larson DW, Cima RR, Sarmiento JM, Wolff BG, Heimbach JK, Pemberton JH (2008) Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg 95:882-6
19. Bjoro K, Friman S, Höckerstedt K, Kirkegaard P, Keiding S, Schrumpf E, Olausson M, Oksanen A, Isoniemi H, Hjortrup A, Bergan A, Ericzon BG (1999) Liver transplantations in the nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol 7:714-722
20. Burak KW, Angulo P, Lindor KD (2003) Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroeneterol 98:1155-8
21. MacFaul GR, Chapman RW (2004) Sclerosing cholangitis. Curr Opin Gastroenterol 20:275-280
22. Gores GJ (2000) Early detection and treatment of cholangiocarcinoma. Liver Transplant 6(6 Suppl 2):S30-4